New drug copycat tested on healthy people
NCT ID NCT07327697
Summary
This early-stage study aims to see how a new drug candidate, QL2302, compares to an existing drug, Tezspire, in healthy people. Researchers will measure how the body processes the drugs, check for safety issues, and see if they trigger an immune response. The goal is to gather initial data to see if QL2302 behaves similarly to the original drug.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.